TOP6BL

TOP6BL (TOPOVIBL) is the obligate partner of SPO11, together forming the TOPOVIL complex that catalyzes the programmed DNA double-strand breaks (DSBs) which initiate meiotic recombination; loss of TOP6BL abolishes meiotic DSBs and arrests gametogenesis (PMID:26917764). Purified recombinant SPO11 and TOP6BL assemble as a monomeric 1:1 complex that, upon dimerization into a 2:2 assembly, cleaves DNA and remains covalently attached to the 5' broken ends; cleavage depends on SPO11 active-site residues and divalent metal ions but is ATP-independent, and TOP6BL itself binds neither ATP nor exhibits ATPase activity, distinguishing the complex biochemically from ancestral topoisomerase VI (PMID:39972129, PMID:39972130, PMID:39972125, PMID:38966985). TOP6BL binds DNA with a preference for branched or bent geometries and increases the affinity of the complex for DNA ends beyond that of SPO11 alone, indicating both a DNA-architecture-sensing role and a post-cleavage end-binding function (PMID:39972129, PMID:39972130, PMID:39972125, PMID:38966985). TOP6BL activity is governed through its central region and through direct interaction with the accessory factor REC114, whose PH domain is bound competitively by TOPOVIBL, IHO1, and ANKRD31, making REC114 a regulatory platform for mutually exclusive meiotic interactions; point mutations that disrupt the TOP6BL–REC114 interaction strongly reduce genome-wide DSB activity, and disruption of TOP6BL self-dimerization or its central region likewise causes meiotic arrest (PMID:36396648, PMID:41211863, PMID:37431931). In humans, autosomal-recessive loss-of-function mutations in TOP6BL abolish meiotic DSB formation and cause meiotic arrest with non-obstructive azoospermia in males and oocyte maturation failure in females, phenotypes recapitulated in equivalent mouse knock-in models (PMID:36732965, PMID:41211863). Separately, CGG-repeat expansion at the 5' end of the gene underlies the folate-sensitive fragile site FRA11A through CpG-island hypermethylation and transcriptional silencing (PMID:18160775).

1. 2016 High

   Established that TOP6BL is a SPO11 partner essential for the initiating event of meiotic recombination, answering whether SPO11 acts alone or within a defined complex.

   Evidence Reciprocal Co-IP and loss-of-function mouse genetics with DSB-formation assay

   PMID:26917764

   Open questions at the time

   • Did not establish the stoichiometry or catalytic mechanism of the complex
   • Did not define TOP6BL's specific contribution distinct from SPO11
2. 2020 High

   Connected TOP6BL to human disease by showing biallelic loss-of-function causes meiotic arrest and infertility in both sexes, demonstrating conservation of its DSB-initiating role.

   Evidence Whole-exome sequencing of azoospermia/oocyte-failure patients plus mouse knock-in models with DSB and histological readouts

   PMID:36732965

   Open questions at the time

   • Did not resolve which molecular interaction each mutation disrupts
   • Did not address residual partial-function alleles
3. 2022 High

   Identified REC114 as a direct TOPOVIBL partner and mapped the interacting domains, defining how the catalytic complex is recruited or regulated.

   Evidence Structural domain mapping plus point-mutation knock-in mice with genome-wide DSB monitoring

   PMID:36396648

   Open questions at the time

   • Differential effects between oocytes and spermatocytes not mechanistically explained
   • Did not show how REC114 binding translates into DSB-site selection
4. 2023 Medium

   Reframed REC114 as a competitive regulatory platform by showing IHO1 binds the same PH-domain surface as TOPOVIBL and ANKRD31, implying mutually exclusive partner exchange.

   Evidence AlphaFold2 modeling combined with biochemical binding assays

   PMID:37431931

   Open questions at the time

   • TOPOVIBL competition inferred from shared surface rather than directly measured
   • In vivo consequence of exchange dynamics not tested
5. 2024 Medium

   Characterized TOP6BL as a monomeric, ATP-independent DNA-architecture sensor, dissociating it from the ATPase activity of ancestral topoisomerase VI subunits.

   Evidence Purification and in vitro ATP-binding/DNA-binding and structural assays of TOPOVIBLΔC25

   PMID:38966985

   Open questions at the time

   • DNA-geometry preference not validated in vivo
   • Single-lab biochemistry without functional confirmation of bent-DNA sensing
6. 2024 High

   Provided high-resolution structural insight into DNA end-binding and cleavage determinants of the Spo11 core complex, including variation in the Top6BL homolog.

   Evidence Cryo-EM of yeast Spo11–Rec102–Rec104–Ski8 bound to DNA with yeast functional validation

   PMID:39304764

   Open questions at the time

   • Structure is of yeast homologs, not mammalian TOP6BL
   • Did not capture the catalytically active cleaving state directly
7. 2025 High

   Achieved full biochemical reconstitution, proving the SPO11-TOP6BL complex is itself the catalytic DSB machine: a 1:1 monomer that dimerizes to a 2:2 assembly, cleaves DNA Mg2+-dependently and ATP-independently, forms covalent 5' attachments, and uses TOP6BL for enhanced DNA-end binding.

   Evidence In vitro reconstitution with purified proteins, active-site and Mg2+-binding mutagenesis, deep sequencing of products, AlphaFold 3 modeling, and knock-in mouse validation across independent labs

   PMID:39972125 PMID:39972129 PMID:39972130

   Open questions at the time

   • Trigger for the monomer-to-dimer transition in vivo not defined
   • How accessory factors gate catalysis in cells not reconstituted
8. 2025 Medium

   Resolved how distinct patient mutations impair TOP6BL function, separating partner-binding defects from self-dimerization defects and pinpointing the central region as critical.

   Evidence Protein-binding and self-dimerization assays for NOA variants plus mouse central-region deletion with meiotic-arrest phenotype

   PMID:41211863

   Open questions at the time

   • Single-lab functional characterization
   • Mechanism by which self-dimerization promotes DSB activity not structurally resolved

• How REC114-mediated partner competition, DNA-architecture sensing, and the monomer-to-dimer transition are coordinated in time and space to select DSB sites in vivo remains open.
• No in vivo demonstration of TOP6BL bent-DNA sensing driving site choice
• Regulation of dimerization timing during meiotic prophase unresolved